Paul Gunn, CEO and President of Soricimed participates in round table discussion on R & D in the Atlantic Region.
March 19, 2012
Paul Gunn, CEO and President of Soricimed Biopharma Inc., was a member of a round table to discuss innovation and R&D funding in the Atlantic region. The round table was hosted by Industry Canada Minister of State (Science and Technology) Gary Goodyear, in Halifax on 19 March, 2012.



